In response to the COVID-19 pandemic, scientists around the world have joined together in applying their skills and technologies to fight this global threat. Some of the most promising technologies to fight the coronavirus are based on oligonucleotide therapeutics. In an effort to promote public awareness of these drugs and how they could stop SARS-CoV-2, the Oligonucleotide Therapeutics Society (OTS) has released two informational videos, one for the general public and one for scientists. Many of our members, who are on the forefront of this work, contributed to these videos which are hosted by past OTS president Dr. Art Krieg. Please scroll down to see both videos.
Oligonucleotide Therapeutics: New Drugs That Could Stop SARS-CoV-2
This webinar is suggested for nonscientists who are not familiar with oligonucleotides, but who are interested in learning how new biotechnologies can help to stop this pandemic. Starting with the biology basics, Dr. Art Krieg, Past President of the Oligonucleotide Therapeutics Society, explains what oligonucleotide therapeutics are, and some of the life-saving drugs that have been developed. The focus then is on the application of these technologies to prevent or treat Covid-19, including the vaccines that are now in the news, and explaining the way they work based on general scientific principles that should be familiar to most people. A key point made is the speed with which the new generations of oligonucleotide drugs (including mRNA and DNA vaccines) can be developed against a novel pandemic such as this. OTS members may find this webinar helpful for their family members who don’t understand what they are doing and why it is important!